Chemomab Therapeutics Ltd... (CMMB)

AI Score

Unlock

1.12

-0.04 (-3.45%)

At close: Apr 17, 2025, 3:57 PM

1.17

4.46%

After-hours: Apr 17, 2025, 07:14 PM EDT

Chemomab Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Net Income	-2.96M	-3.48M	-3.63M	-3.87M	-3.45M	-4.07M	-7.97M	-8.75M	-8.27M	-8.08M	-6.19M	-5.1M	-5.04M	-2.97M	-2.77M	-1.7M	-1.95M	-1.22M	-1.08M	-1.7M	14.74M	-7.17M
Depreciation & Amortization	n/a	n/a	n/a	n/a	16.17K	18.94K	16K	16K	14K	17K	14K	13K	11K	9K	7K	7K	6K	8K	5K	5K	-50K	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	238K	130K	639K	484K	740K	836K	761K	874K	1.01M	441K	527K	43K	33K	23K	28K	46K	-935K	322K
Other Working Capital	n/a	n/a	n/a	n/a	-332.6K	315.47K	-301K	538K	1.37M	2.16M	-232K	355K	269K	-71K	-3.4M	80K	291K	494K	8K	-306K	-4.07M	n/a
Other Non-Cash Items	2.96M	3.48M	3.63M	3.87M	347.69K	1.84M	531.93K	-12.88K	-20.37M	1.13M	819.42K	750.63K	1.01M	456.88K	514.14K	-221.68K	21K	-1.99M	-2.21M	11K	-5.8M	6.85M
Deferred Income Tax	n/a	n/a	n/a	n/a	-256.43K	-1.64M	-531.93K	12.88K	20.37M	-1.13M	-819.42K	n/a	-1.01M	n/a	n/a	n/a	-21K	1.99M	2.21M	-11K	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	-556.44K	-1.28M	-171K	1.07M	1.81M	1.97M	-286K	506K	1.12M	-62K	-3.37M	361K	357K	292K	175K	-269K	-4.04M	n/a
Operating Cash Flow	n/a	n/a	n/a	n/a	-3.9M	-5.13M	-7.49M	-7.19M	-5.7M	-5.25M	-5.7M	-3.71M	-2.89M	-2.58M	-5.61M	-1.29M	-1.55M	-901K	-873K	-1.91M	3.92M	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	-29.46	6.93	-2K	-1K	-1K	-42K	-11K	-14K	-134K	-240.89	-102K	-3K	-1K	-20K	-7K	-10K	343K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-19.45M	-5M	-21.43M	n/a	-2K	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	1.86M	3.92M	-4.27M	14.43M	9.38M	6.02M	1.74M	2.4M	n/a	n/a	n/a	989.65	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	1.72M	3.99M	-4.27K	14.43K	-32.54K	92.26K	1.74M	2.4M	4K	2.29K	-20.5M	1K	-2K	n/a	-22K	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	1.86M	3.92M	-4.27M	14.43M	9.35M	6.07M	1.73M	2.38M	-19.58M	-5M	-20.6M	-2K	-3K	-20K	-29K	-10K	343K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.21M	n/a	n/a	n/a	n/a	-72K	n/a	n/a	n/a	n/a	n/a	n/a	-30.41M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	2.14M	3K	1.37M	n/a	82K	39K	22K	n/a	n/a	n/a	n/a	2.43M	63K	562K	125K	500K	17.86M	n/a
Financial Cash Flow	n/a	n/a	n/a	n/a	2.14M	5.74K	1.37M	-2.97K	-869K	39K	22K	12.03K	-81K	-72K	13.43M	47.8M	563K	562K	3.13M	500K	-12.54M	n/a
Net Cash Flow	n/a	n/a	n/a	n/a	140.2K	-1.23M	-10.39M	7.25M	2.78M	858K	-3.95M	-1.33M	-22.56M	-7.65M	-12.78M	46.5M	-999K	-355K	2.25M	-1.42M	-8.28M	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	-3.9M	-5.13M	-7.49M	-7.19M	-5.7M	-5.3M	-5.71M	-3.73M	-3.03M	-2.58M	-5.71M	-1.3M	-1.56M	-921K	-880K	-1.92M	4.26M	n/a